Financials
- Market Capitalization 254.15 M
- Employee 44
- Founded 2015
- CEO N/A
- Website www.surrozen.com
- Headquarter Delaware, United States
- FIGI BBG00XY94S95
- Industry 生物技术
总收入
净利润
每股基本收益(基本 EPS)
总债务
自由现金流
现金及现金等价物
市盈率
-0.7
市销率
0.05
Related tickers
| # | 姓名 | 价格 | 24小时 % | 7天 % | 一个月 % | 一年 % | 市值 | 最近7天 | |
|---|---|---|---|---|---|---|---|---|---|
| 3407 | IKT Inhibikase Therapeutics, Inc. - Common Stock | 2.06 USD | +5.10% | +0.49% | +21.18% | +6.19% | 271.99 M USD | ||
| 3410 | GLSI Greenwich LifeSciences, Inc. - Common stock | 19.03 USD | +2.48% | +2.48% | -22.07% | +78.02% | 279.33 M USD | ||
| 3434 | NAGE Niagen Bioscience, Inc. - Common Stock | 3.30 USD | -4.90% | -4.35% | -5.17% | -33.73% | 262.83 M USD | ||
| 3447 | ALXO ALX Oncology Holdings Inc. - Common Stock | 2.01 USD | +2.03% | -14.83% | +26.42% | +336.96% | 270.47 M USD |